Historical record - last NADAC publication: 7/16/2018
Product Information
REVATIO 20 MG TABLET is a brand product labeled by Pfizer Inc., priced at $46.6786 per EA under NDC 00069419068. Its NADAC has been published 294 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the sildenafil citrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Pfizer Inc.NDC
00069419068
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
7/16/2018
Active Ingredients
SILDENAFIL CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA021845On Market Since
6/3/2005
Pharmacological Classes
Price Statistics
The NADAC for REVATIO 20 MG TABLET has been published 294 times since Nov 28, 2013, and over the history we have for it it has risen 122.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.6786 per EA |
|---|---|
| All-time high | $51.0852 (Jul 11, 2018) |
| All-time low | $20.9789 (Nov 28, 2013) |
| Median price | $35.6115 |
| Average price | $35.8050 |
| Largest weekly change | +9.4% (Jun 8, 2016) |
| Weeks tracked | 294 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the sildenafil citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REVATIO 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REVATIO 20 MG TABLET, manufactured by Pfizer Inc., is $46.6786 per EA (NDC 00069419068), effective Jul 10, 2019.
How has the price of REVATIO 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for REVATIO 20 MG TABLET has risen 122.5%. It has been tracked across 294 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for REVATIO 20 MG TABLET?
Since Nov 28, 2013, the NADAC for REVATIO 20 MG TABLET has ranged from a low of $20.9789 (Nov 28, 2013) to a high of $51.0852 (Jul 11, 2018), with a median of $35.6115 per EA.
Are there cheaper alternatives to REVATIO 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REVATIO 20 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures REVATIO 20 MG TABLET?
REVATIO 20 MG TABLET (NDC 00069419068) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification